ABSTRACT. Although fetal asphyxia, i.e. hypoxemia, acidosis, and hypercapnia, increases plasma arginine vasopressin (AVP) >40-fold, hypoxemia and metabolic acidosis occurring independently cause only 5-fold and 2-fold increases, respectively. To determine the effects of hypercapnia on AVP release, we examined the effects of acute hypercapnia on AVP secretion in six pregnant sheep and their fetuses a t 135 f 4 d (x f SD), exposing the ewe successively to room air, 30% 02, 30% O 2 plus 10% C 0 2 , 30% 02, and room air, and monitoring uterine blood flow, a s well as maternal and fetal mean arterial pressure, heart rate, arterial blood gases, and plasma AVP and catecholamines. Oxygen exposure had no effect on the ewe or fetus. During O 2 plus COz exposure, the ewes and fetuses developed hypercapnia in the absence of hypoxia, arterial C 0 2 tension increasing to 8.38 f 0.87 kPa (62.9 f 6. respectively. Hypercapnia alone is not a major determinant of AVP secretion in the mother or fetus; thus, the marked rise in fetal AVP secretion observed during asphyxia1 insults may reflect interaction between the effects of hypercapnia and hypoxemia. (Pediatr Res 30: 368-374,1991) Abbreviations MAP, mean arterial pressure E, epinephrine NE, norepinephrine PaOz, arterial O 2 tension PaCOZ, arterial COz tension ANOVA, analysis of variance pH,, arterial p H Alterations in the homeostatic milieu trigger a complex series of events that serve to protect the individual organism against environmental insults. Asphyxia, i.e. the simultaneous occurrence of hypoxemia, acidosis, and hypercapnia, is a striking illustration of an intense "stress," and subsequent adaptive responses reflect a complex interaction of factors related to the metabolic, neuroendocrine, and cardiovascular systems. Although these responses have been examined in adult animals of several species (1-6), the ontogeny of these responses during fetal development is not fully understood.
rence of hypoxemia, acidosis, and hypercapnia, is a striking illustration of an intense "stress," and subsequent adaptive responses reflect a complex interaction of factors related to the metabolic, neuroendocrine, and cardiovascular systems. Although these responses have been examined in adult animals of several species (1-6), the ontogeny of these responses during fetal development is not fully understood.
In fetal sheep the response to stress has been characterized by increased secretion of AVP and adrenal catecholamines (7) . By using the fetal sheep as a model, we and others (5, (8) (9) (10) (11) (12) have observed that fetal asphyxia, regardless of method of induction, results in substantial increases in plasma AVP concentrations,
i.e. >40-fold rises over baseline levels. In contrast, we have shown ( I I) that during moderate fetal hypoxemia, i.e. a 45% decrease in Pa02 without alterations in either arterial pH or PcoZr plasma levels of AVP rose only modestly (5-fold over baseline values). Furthermore, induction of marked metabolic acidemia had little effect on fetal AVP secretion, i.e. only a 2-fold rise over baseline levels (I 3). Because neither hypoxemia alone nor pure metabolic acidosis resulted in the substantial increase in plasma AVP seen during fetal asphyxia, the role of hypercapnia in fetal secretion of AVP, as well as the interaction of these variables, remained to be elucidated.
Catecholamines are also released during asphyxia. Rose ef a/. (14) demonstrated that acute hypercapnic acidosis resulted in increased circulating levels of both E and NE in adult dogs. However, NE was the predominant catecholamine released, especially when hypercapnia was combined with hypoxemia. They suggested that the major source of NE was the sympathetic nerve terminals. They also observed an increase in MAP and heart rate in response to hypercapnia. No one, to our knowledge. has addressed the effects of acute hypercapnia on circulating catecholamines in a fetal animal. Moreover, the relationship between plasma levels of these hormones and cardiovascular responses during hypercapnia has not been examined in the fetus.
Therefore, the purpose of the study presented here was to determine the effects of acute hypercapnia on fetal secretion of AVP, dopanline, NE. and E, to examine the concomitant fetal hemodynamic responses, and to compare these alterations with those occurring simultaneously in the pregnant ewe.
MATERIALS AND METHODS
Received October 26, 1990 ; accepted June 17, 1991. .4nimu/prepu~ulion. Pregnant sheep ( n = 6) of mixed Western Correspondence: Charles R. Rosenfeld ploying sterile procedures, the maternal abdomen was opened, the pregnant uterus was delivered, and a fetal hindlimb was brought out through a uterine incision. Polyvinyl catheters were implanted into a fetal femoral artery (7.5 cm) and vein ( I 5 cm). The fetal hindlimb was returned to the amniotic sac, an amniotic catheter was inserted, and the uterus was closed with a double layer of sutures. The uterus was then returned to the maternal abdomen, and electromagnetic flow probes (Micron Instruments Inc., Los Angeles, CA) were implanted around both main uterine arteries proximal to their bifurcation. The fetal catheters and flow probe leads were brought out of the maternal abdomen through a stab wound in the fascia, and the abdominal incision was closed. Polyvinyl catheters were implanted in both maternal femoral arteries (I5 cm) and veins (20 to 25 cm). All catheters were filled with heparinized saline, closed with sterile pins, and brought out to the maternal flank with the flow probe leads via a S.C. tunnel, where they were maintained in a canvas pouch attached to the skin with steel pins. Pregnant animals received intramuscular mezlocillin (0.5 g) and penicillin (600 000 U) on the day of surgery and the 2 following days. Mezlocillin (50 mg) was also instilled in the amniotic sac at surgery and every other day thereafter. After surgery, all animals were maintained in individual stalls in the laboratory and had free access to water and food (Purina Commercial Creep Chow 11, G: Ralston-Purina Co., St. Louis, MO). Studies were performed at least 5 d postoperatively. Fetal sheep with abnormal blood gases or pH were not studied. Experimental protocol. Acute hypercapnia was induced in pregnant ewes and their fetuses by sequentially exposing the ewe to the following gas mixtures: room air for 30 min, 30% O-, for 30 min, 30% O2 plus 10% C 0 2 for 30 min, 30% Oz for 30 min, and room air for 60 min. To obtain changes in inspired O2 and C02, a plastic bag connected to a gas blender was loosely placed over the head of the ewe at the end of the initial room air period and the appropriate gas mixture was administered at -10 L/ min. As previously reported. this procedure was well tolerated in all animals (1 1). In preliminary experiments, we observed that some ewes developed acute hypoxemia and metabolic acidosis in conjunction with respiratory acidosis; therefore, to prevent fetal and/or maternal hypoxemia as a confounding variable, we administered 30% O2 to the ewe, establishing control room air and hyperoxia periods both before and after each exposure to COz. This protocol was approved by the Institutional Review Board for Animal Research. Two animals were studied twice and were allowed 2 to 4 d between experiments. There was no gestational age effect noted in these experiments. MAP in the lower abdominal aorta of the ewe and fetus was continuously monitored with pressure transducers (model 4-327-1019; Bell and Howell, Pasadena, CA), and the output was recorded by means of a two-channel pen recorder (model 220; Brush Instruments, Div. Clevite Corp., Cleveland, OH). Intraamniotic pressure was recorded with another recorder electronically integrated with the first; the reported values for MAP are corrected for amniotic pressure. Heart rates were obtained at intervals from a direct recording of the phasic signal. Maternal respiratory rates were also obtained at the same intervals from direct observation. Uterine blood flow was monitored continuously with square-wave electromagnetic flowmeters (model RC1000; Micron Instruments, Los Angeles, CA) and was recorded by means of another two-channel recorder, which also was electronically integrated. Results are presented as total uterine blood flow.
Heparinized blood was obtained from the fetal and maternal femoral artery catheters for measurements of blood gases and pH (0.5 mL), hematocrit (0.2 mL), AVP (2.0 mL), and catecholamines (I .0 mL). Samples were collected at 15 min in room air, at 10 and 20 min in 30% 02, at 10-min intervals in 30% O2 plus C02, at 15 and 30 min in 30% O2 after the end of C 0 2 exposure, and then at 30 rnin, 60 min. and 20 h in room air. Additional blood for measurement of AVP also was obtained 7.5 min after the end of C 0 2 exposure. Each sample of fetal blood collected for AVP and catecholamine measurements was centrifuged immediately, the plasma was removed, and the erythrocytes were resuspended in a volume of sterile isotonic saline equal to the plasma volume and reinfused into the fetus in the manner previously reported (1 5). This procedure has been shown to have no effect on AVP secretion (13) . Maternal blood was handled similarly, but red cells were not reinfused. Fetal (0.5 mL) and maternal (0.5 mL) plasma osmolalities were measured at each of these times in the first four experiments. Fetal plasma lactate levels (0.4 mL) were determined in two initial experiments.
Samples of amniotic fluid (2 mL) were collected at 15 min in room air, at 20 rnin in 02, at 10-min intervals in COz plus 0 2 , at 15 and 30 min in O2 after ending COz, and at 30 min, 60 min. and 20 h in room air for measurement of AVP.
Assav.~. Arterial blood samples for blood gases, pH, and hematocrit were collected in 1.0-mL heparinized syringes and were kept on ice until analyzed. The blood gases and pH were measured with a pH/gas analyzer (model 113; Instrumentation Laboratory, Lexington, MA). The hematocrit was measured on these samples by the micro-method of Wintrobe. Plasma osmolality was measured by freezing-point depression with an automatic osmometer. Lactic acid concentrations were determined by using a lactate dehydrogenase enzymatic assay on plasma (200 pL) after deproteinization with 8% perchloric acid. Blood samples for measurement of AVP were collected in chilled heparinized syringes and were immediately transferred to sterile plastic centrifuge tubes. After centrifugation at 10 000 x g for 60 s in a Beckman microfuge, the plasma was removed. frozen immediately on dry ice. and stored at -20°C until the time of assay. Plasma AVP was measured by RIA with rabbit antiserum R-71. The production of antiserum R-71 and the validation of this RIA have been described by Skowsky et al. (16) . At the time ofassay, the samples were thawed and acidified (pH 2.0) by the addition of 0.1 mL of I N HCI and AVP was extracted from the plasma by the methods of Crofton et ul. (17) with CI8 Sep Pak cartridges (Waters Associates, Milford, MA).
The recovery of AVP is 97 + 2.0%. The extract was evaporated to dryness, and the residue was resuspended in 400 pL of assay buffer. The RIA for AVP in our laboratory has been described (1 1). The sensitivity of the assay is I8 pmol/L.
Blood samples for measurements of catecholamines were centrifuged at 10 000 x g for I min, and the plasma was mixed with an equal volume of 0.6 M perchloric acid containing 0.1% EDTA. The supernatant was stored at -20°C until the time of assay for measurement of dopamine, NE, and E. Catecholamines were quantified by the radioenzymatic assay of Ben-Jonathan and Porter (18) . This assay is linear from 0 to 5 pg for each catecholamine and has a sensitivity of 10 to 30 pg.
Data analjlsis. Repeated measures ANOVA was used to analyze changes over time; when significance was observed with an F value corresponding with p < 0.05, the data were further analyzed by Duncan's multiple range test for each variable and/ or paired t test. Regression lines were obtained by the leastsquares method. These analyses were performed by using the SAS system (SAS Institute Inc., Cary, NC) on a VAX computer. The data are presented as means and one SEM unless otherwise specified.
RESULTS
Res~~iratory and metcrholic crltertr/ions. Baseline data for maternal and fetal (Table I ) arterial blood gases, pH, and hematocrit are similar to data previously reported from our laboratory (1 1, 13, 19) . Maternal Pao2 increased significantly at 10 min of Oz exposure ( Fig. I ) and remained elevated throughout C 0 2 exposure, returning to control levels after the animals were allowed to breathe room air. By 10 rnin of C 0 2 inhalation, the ewes developed significant respiratory acidosis [Paco2 = 7.06 + 1.47 increased and remained elevated during hypercapnia but returned to control levels more rapidly than heart rate. decreasing to basal values within 30 min after the exposure to C 0 2 was stopped. Despite these maternal hemodynamic responses, there were no significant changes in uterine blood flow in response to hypercapnia.
Among mammals, different forms of stress result in increased secretion of AVP and catecholamines. In the fetus, hypoxemia (I I), asphyxia (8, (10) (11) (12) 15) , hypotension (20) . hemorrhage (21. 22) . parturition (12, 23) , cord occlusion (9) , and increases in plasma osmolality (24) are potent stimuli resulting in substantial increases in plasma AVP concentrations. Although the effects of hypovolemia and hyperosmolality on hormone secretion are better understood, it is unclear how those stresses associated with changes in arterial blood gases and pH result in increased fetal AVP or catecholamine release. Nonetheless, "hypoxia" has been suggested as the primary stimulant. In view of this, we have attempted to elucidate the mechanisms responsible for AVP 
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The fetal cardiovascular responses to hypercapnia are shown in Figure 4 . In contrast to that observed in the ewe, fetal heart rate was unchanged during hypercapnia. However, toward the end of CO2 exposure, heart rate began to rise and, during the recovery period, there was development of significant tachycardia, which persisted during the second period of Oz exposure, gradually returning to control levels by 20 h. The response in corrected fetal MAP was quite variable (Fig. 4) ; although there was a 20% increase in fetal MAP during and immediately after Plastna A VP. Plasma concentrations of maternal and fetal AVP before, during, and after C 0 2 exposure are presented in Table 2 and illustrated in Figure 5 . Control values are similar to those previously reported by us for ewes or fetal sheep studied at a similar gestational age (1 3). Despite the presence of moderately severe hypercapnia. there were only modest and, interestingly, to account for the variability seen. Plasrna catecliolamint.~. The pattern of change in plasma catecholamine concentrations during successive gas exposures is presented in Table 2 . Maternal plasma concentrations of catecholamines were highly variable; therefore, we used the log values to analyze these data. Although there was a 3-to 4-fold increase in maternal NE and E levels between exposure to Oz alone and O2 plus COz exposure and a gradual return to baseline thereafter, these changes were not statistically significant Cp > 0.1 : ANOVA).
Nonetheless, a significant, albeit a weak, relationship was observed between maternal Paco2 and NE ( r = 0.37; p = 0.006) and Pace? and E ( r = 0.53; p < 0.001). There were also no significant changes in plasma dopamine. The pattern of change in fetal plasma catecholamine levels was similar to that seen in the ewe. Again, there was marked variability and data were analyzed as noted above. Fetal plasma concentrations of dopamine and NE were not significantly changed. On the other hand, fetal plasma concentrations of E increased 4-fold at 30 min of COz exposure (11 = 0.0 I) compared with O2 alone; as in the ewe, levels gradually returned to values not different from control after the end of hypercapnia. When we examined the relationship between fetal Pace? and plasma catecholamines, there was a significant correlation only between Paco2 and E ( r = 0.58; p < 0.001). release in response to asphyxia/hypoxemia by examining each of the components of an asphyxia1 episode ( 1 I, 13).
During acute asphyxia, i.e. the simultaneous occurrence of hypoxemia, acidosis, and hypercapnia, we and others have reported a 40-to 240-fold rise in ovine fetal plasma AVP (5, (8) (9) (10) (11) (12) . In contrast, exposure to hypoxemia [Pao2 as low as 1.47 kPa (1 1 mm Hg)] in the absence of either metabolic acidosis or hypercapnia (i.e. respiratory acidosis) results in relatively small increases in plasma AVP (1 1). Because this suggested that hypoxemia alone may not be the major determinant of AVP release during asphyxia, we examined the role of acute metabolic acidemia in the release of this peptide hormone in fetal sheep of similar gestational ages (13) . In those studies, NH4C1 infusion resulted in a fall in fetal arterial pH to 7.04 ? 0.05, but only a 2-fold rise in plasma AVP concentration, which was not related to the fall in pH. Thus, it was evident from these studies that neither severe metabolic acidosis nor a 45% fall in Pao2 was solely responsible for the marked increases in plasma AVP reported to occur during acute fetal asphyxia.
In the studies presented here, we sought to determine the role of acute hypercapnia and respiratory acidosis in the fetal secretion of AVP. Although this has been examined in adult animals (4, 25, 26) , it has not been studied in the fetus. In preliminary studies, ewes frequently developed hypoxemia and metabolic acidosis during acute hypercapnia; therefore, we chose to rnaintain oxygenation by providing 30% inspired 0 2 . In these studies, oxygen exposure had no effect on maternal or fetal cardiovascular or hormonal parameters. Maternal and fetal hypercapnia occurred simultaneously and within 10 min of maternal exposure to 30% O2 plus 10% COz. resulting in the development of persistent and significant respiratory acidosis in the absence of either hypoxia or metabolic acidosis. However, the gradual rise in maternal and fetal plasma concentrations of AVP did reach significance over a broad range of hypercapnia, i.e. up to 10.7 kPa (80 mm Hg). Our observations in the ewe are consistent with those of Raff et al. (25) . who, in studies of normoxic hypercapnia in anesthetized adult dogs. achieved values for Pacoz and pH, similar to those observed by us in the unanesthetized pregnant ewe. Thus, similar mechanisms for AVP secretion may be at work in the mother and fetus. It is noteworthy that, in the adult, Raff et al. In the studies presented here, we examined other variables that might affect AVP secretion, including uteroplacental blood flow, and none of these factors was significantly altered. For example, decreases in 0 2 , alterations in plasma osmolality, and decreases in MAP did not occur. Stimulation of the peripheral chemoreceptors has also been shown to increase AVP secretion in the adult (26) . Although maternal carotid chemoreceptors were obviously stimulated, as evidenced by the 50% rise in heart rate, the modest rise in plasma AVP was not significant. It may be that the simultaneous rise in maternal MAP acted to attenuate maternal AVP secretion, as suggested by several investigators (2, 3, 26) , thereby resulting in nonsignificant increases. This is supported by the achievement of maximum maternal AVP levels after COz exposure when MAP had returned to control levels. A similar series of events may have occurred in the fetus, because plasma AVP also did not attain maximum values until the end of C 0 2 exposure, when fetal heart rate was significantly elevated. In contrast to that in the mother, the rise in fetal MAP was modest (-20%) and was not significant after correction for changes in amniotic sac pressure. Thus, the potential inhibitory effect of fetal MAP on AVP secretion is unclear. Moreover, the effects of increases in fetal MAP and chemoreceptor stimulation on AVP secretion have not been studied. Atrial natriuretic peptide has also been shown to attenuate or inhibit AVP secretion in the adult (27) (28) (29) . We recently reported that increases in fetal MAP will cause substantial increases in right atrial pressure and the secretion of atrial natriuretic peptide (30) . Therefore, it is possible that this series of events would inhibit or attenuate AVP secretion in both the ewe and fetus. Further studies are necessary to prove this.
Catecholamines are also released during asphyxia (2, 14) . In the studies presented here, both NE and E were secreted by the pregnant ewe during hypercapnia, although this was quite variable. Furthermore, the relative increases in both catecholamines were similar, 2-to 3-fold, suggesting that the primary source of maternal catecholamines might be the sympathetic nerve terminals as well as the adrenal medulla-conclusions similar to those obtained in adult dogs (14) . In the fetus, NE and E also increased during hypercapnia, but only the latter reached significance, and both gradually fell after ending COL exposure. In contrast to that seen in the ewe, the relative rise in E was more than 2-fold greater than that of NE, 3 16 verszu 142%, suggesting that during fetal hypercapnia the predominant source of catecholamines is the adrenal medulla, a conclusion consistent with the observations of others (7) . The differences between the adult and fetal animals in their levels and distribution of catecholamines may thus be explained on the bas~s of the relative contribution to the circulating pool of catecholamines from these two sources. The observations presented here suggest that the primary fetal and maternal hormonal response to the degree of hypercapnia experienced is the increased release of catecholamines, particularly E, rather than AVP.
It is noteworthy that fetal and maternal plasma levels of catecholamines increased maximally during COz exposure, whereas the maximum rise in plasma concentrations of AVP was not attained until the end, or soon after the end, of CO? exposure. Thus, the observed rise in MAP likely reflects the effects of the catecholamines or another pressor agent rather than those of AVP. This would also explain the cardiovascular responses previously seen during acute fetal hypoxemia ( 1 I), where the increase in fetal MAP also occurred before the rise in plasma levels of AVP. That more than one agent is associated with the fetal cardiovascular responses to hypoxemia or stresses has been suggested by others (3 1, 32) . It also is possible that the earlier increase in catecholamine secretion might be responsible in part for the subsequent rise in plasma AVP levels. This is supported by in vivo and in vitro studies of the adult, in which catecholamines have been shown to modulate AVP secretion (33) . Moreover, neurohistochemical studies of adult tissues have clearly established that the magnocellular neurons are surrounded by catecholamine-containing varicosities, especially NE (34) . Thus, the relatively "late" and possibly attenuated rise in plasma AVP in the mother and fetus, although nonsignificant. might reflect the effect of catecholamine simulation rather than that of hypercapnia. In contrast, Block el al. (35) have suggested that in fetal sheep a]-adrenergic stin~ulation may serve to inhibit AVP secretion. Alternatively, both fetal and maternal AVP responses to hypercapnia may be slow as compared with catecholamine secretion.
In the adult, Raff et a/. (25) have reported that synergism may exist between the different components of asphyxia in the secretion of AVP. It is noteworthy that, in a preliminary experiment (Fig. 6 ) in which Pacoz increased from 5.33 to 12.0 kPa (40 to 90 mm Hg) and O2 content fell from 9.8 to 5.7 vol%, plasma AVP levels rose to 4550 pmol/L, a value 40-fold greater than that seen in this study, where oxygenation was maintained. This observation can be extrapolated to suggest that oxygen delivery to the neurohypophysis, measured as the product of blood flow times O2 content, determines if there is substantial tissue hypoxia/asphyxia and thus AVP release. Although Paor was maintained, this probably reflects a shift in the oxygen dissociation curve due to the changes in pH, and Pacoz. This animal, therefore, demonstrates that asphyxia. i.e. simultaneous alterations in CO?, 0 2 , and pH, may be important in fetal AVP release and that synergism likely occurs in vivo. The minimal effects of each asphyxia1 co~uponent seen in this and earlier studies ( 1 1, 13) suggest that responses to asphyxia reflect a complex phenomenon, resulting in the release of local factors that act on the magnocellular neurons, potentially releasing other yet unidentified circulating vasopressinergic substances or stimulating the CNS directly.
